An Economic Model of Human Cooperation Based on Indirect Reciprocity and Its Implication on Environmental Protection

Por Dai, Jugui, Zhang, Yiqiang, Shi, Victor
Publicado no Int J Environ Res Public Health (2018)

Supply Chain Partner Communication in a Managed Programme in the UK Water Industry: A Case Study with Social Network Analysis

Por Li, Qing, Wang, Shengqiao, Shaw, Nicky, Shi, Victor
Publicado no Int J Environ Res Public Health (2019)

Coordination of a Dual-Channel Pharmaceutical Supply Chain Based on the Susceptible-Infected-Susceptible Epidemic Model

Por Hou, Yanhong, Wang, Fan, Chen, Zhitong, Shi, Victor
Publicado no Int J Environ Res Public Health (2020)

Early box office prediction in China’s film market based on a stacking fusion model

Por Liao, Yi, Peng, Yuxuan, Shi, Songlin, Shi, Victor, Yu, Xiaohong
Publicado no Ann Oper Res (2020)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial

Por Wachter, Rolf, Shah, Sanjiv J., Cowie, Martin R., Szecsödy, Peter, Shi, Victor, Ibram, Ghionul, Zhao, Ziqiang, Gong, Jianjian, Klebs, Sven, Pieske, Burkert
Publicado no ESC Heart Fail (2020)

A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction

Por Vaduganathan, Muthiah, Jhund, Pardeep S, Claggett, Brian L, Packer, Milton, Widimský, Jiri, Seferovic, Petar, Rizkala, Adel, Lefkowitz, Martin, Shi, Victor, McMurray, John J V, Solomon, Scott D
Publicado no Eur Heart J (2020)

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

Por Vardeny, Orly, Claggett, Brian, Kachadourian, Jessica, Desai, Akshay S., Packer, Milton, Rouleau, Jean, Zile, Michael R., Swedberg, Karl, Lefkowitz, Martin, Shi, Victor, McMurray, John J.V., Solomon, Scott D.
Publicado no Eur J Heart Fail (2019)

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and...

Por McMurray, John J. V., Packer, Milton, Desai, Akshay S., Gong, Jim, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean, Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R.
Publicado em 2013

Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIG...

Por McMurray, John J V, Packer, Milton, Desai, Akshay S, Gong, Jianjian, Lefkowitz, Martin, Rizkala, Adel R, Rouleau, Jean L, Shi, Victor C, Solomon, Scott D, Swedberg, Karl, Zile, Michael R
Publicado no Eur J Heart Fail (2014)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial

Por Vardeny, Orly, Claggett, Brian, Packer, Milton, Zile, Michael R., Rouleau, Jean, Swedberg, Karl, Teerlink, John R., Desai, Akshay S., Lefkowitz, Martin, Shi, Victor, McMurray, John J.V., Solomon, Scott D.
Publicado no Eur J Heart Fail (2016)

Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart...

Por Zile, Michael R., Jhund, Pardeep S., Baicu, Catalin F., Claggett, Brian L., Pieske, Burkert, Voors, Adriaan A., Prescott, Margaret F., Shi, Victor, Lefkowitz, Martin, McMurray, John J.V., Solomon, Scott D.
Publicado no Circ Heart Fail (2016)

B-type Natriuretic Peptide During Treatment with Sacubitril/Valsartan: the PARADIGM-HF Trial

Por Myhre, Peder Langeland, Vaduganathan, Muthiah, Claggett, Brian, Packer, Milton, Desai, Akshay S., Rouleau, Jean L., Zile, Michael R., Swedberg, Karl, Lefkowitz, Martin, Shi, Victor, McMurray, John J.V., Solomon, Scott D.
Publicado no J Am Coll Cardiol (2019)

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: resu...

Por Böhm, Michael, Young, Robin, Jhund, Pardeep S., Solomon, Scott D., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Swedberg, Karl, Zile, Michael R., Packer, Milton, McMurray, John J.V.
Publicado no Eur Heart J (2017)

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

Por Seferovic, Jelena P, Claggett, Brian, Seidelmann, Sara B, Seely, Ellen W, Packer, Milton, Zile, Michael R, Rouleau, Jean L, Swedberg, Karl, Lefkowitz, Martin, Shi, Victor C, Desai, Akshay S, McMurray, John J V, Solomon, Scott D
Publicado no Lancet Diabetes Endocrinol (2017)

Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial

Por Chandra, Alvin, Lewis, Eldrin F., Claggett, Brian L., Desai, Akshay S., Packer, Milton, Zile, Michael R., Swedberg, Karl, Rouleau, Jean L., Shi, Victor C., Lefkowitz, Martin P., Katova, Tzvetana, McMurray, John J. V., Solomon, Scott D.
Publicado no JAMA Cardiol (2018)

Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF

Por Vaduganathan, Muthiah, Claggett, Brian L., Desai, Akshay S., Anker, Stefan D., Perrone, Sergio V., Janssens, Stefan, Milicic, Davor, Arango, Juan L., Packer, Milton, Shi, Victor C., Lefkowitz, Martin P., McMurray, John J.V., Solomon, Scott D.
Publicado no J Am Coll Cardiol (2019)

Impaired Left Atrial Function in Heart Failure with Preserved Ejection Fraction

Por Santos, Angela B. S., Kraigher-Krainer, Elisabeth, Gupta, Deepak K., Claggett, Brian, Zile, Michael R., Pieske, Burkert, Voors, Adriaan A., Lefkowitz, Marty, Bransford, Toni, Shi, Victor, Packer, Milton, McMurray, John J. V., Shah, Amil M., Solomon, Scott D.
Publicado no Eur J Heart Fail (2014)

Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction

Por Cannon, Jane A., Shen, Li, Jhund, Pardeep S., Kristensen, Søren L., Køber, Lars, Chen, Fabian, Gong, Jianjian, Lefkowitz, Martin P., Rouleau, Jean L., Shi, Victor C., Swedberg, Karl, Zile, Michael R., Solomon, Scott D., Packer, Milton, McMurray, John J.V.
Publicado no Eur J Heart Fail (2016)

Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

Por Jhund, Pardeep S., Fu, Michael, Bayram, Edmundo, Chen, Chen-Huan, Negrusz-Kawecka, Marta, Rosenthal, Arvo, Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J.V., Packer, Milton
Publicado no Eur Heart J (2015)

Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM‐HF

Por Mogensen, Ulrik M., Køber, Lars, Jhund, Pardeep S., Desai, Akshay S., Senni, Michele, Kristensen, Søren L., Dukát, Andrej, Chen, Chen‐Huan, Ramires, Felix, Lefkowitz, Martin P., Prescott, Margaret F., Shi, Victor C., Rouleau, Jean L., Solomon, Scott D., Swedberg, Karl, Packer, Milton, McMurray, John J.V.
Publicado no Eur J Heart Fail (2017)